"If you have kids, pets, asthma, lungs, a pulmonary system or you just enjoy breathing, this thing is for you," wrote one ...

High prenatal exposure to PFAS linked to increased childhood asthma risk, highlighting concerns over 'forever chemicals' and ...

Babies exposed to PFAS “forever chemicals” in the womb have a higher risk of developing childhood asthma, a new study says. Very high prenatal exposure to PFAS appears to increase children’s risk of ...

A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...

STAT6 degradation is expected to provide a clinical benefit for patients with Type 2 inflammatory diseases, including asthma.

PFAS, or per- and polyfluoroalkyl substances, are a group of human-made chemicals found in everything from food packaging to ...

GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.

A collaborative effort between researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and ...

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track ...

Already known for their ties to immune system dysfunction, cancers and digestive issues, these findings add another notch to ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...